Abstract
Objective
To study the use of transcranial sonography (TCS) in discriminating between patients with dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD).
Methods
Fourteen patients with DLB, 31 with PDD and 73 with PD without dementia (PDnD) were studied with TCS.
Results
All assessable patients with DLB, 97% with PDD, and 94% with PDnD showed at least unilateral hyperechogenicity of substantia nigra (SN). However, bilateral marked SN hyperechogenicity was present in 80% of DLB patients but only in one third of PDD and PDnD patients, and was associated with younger age at disease onset in PD but not in DLB. An asymmetry index ≥ 1.15 of bilateral SN echogenic sizes, estimated by division of larger size by smaller size, was found in 69% of PDD patients but only 20% of DLB patients. Combination of SN echogenic sizes, asymmetry indices and onset age discriminated PDD from DLB with a sensitivity of 96%, a specificity of 80% and a positive predictive value of 93%. TCS of brainstem raphe, thalami, lenticular nuclei, caudate nuclei and ventricle widths did not discriminate between DLB and PDD. Compared with PDnD patients, DLB and PDD patients exhibited significantly larger widths of third ventricle and of frontal horns. In PDD patients, scores on the Unified Parkinson's Disease Rating Scale correlated with widths of third ventricle and of frontal horns.
Conclusions
SN hyperechogenicity is typical for PDD and DLB.However, size, asymmetry and relation of SN hyperechogenicity to age at disease onset discriminate PDD from DLB.
Similar content being viewed by others
References
Duda JE (2004) Pathology and neurotransmitter abnormalities of dementia with Lewy bodies. Dement Geriatr Cogn Disord 17(Suppl 1):3–14
Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW (2002) Parkinson's disease neuropathology: laterdeveloping dementia and loss of the levodopa response. Arch Neurol 59:102–112
Benecke R (2003) Diffuse Lewy body disease – a clinical syndrome or a disease entity? J Neurol 250(Suppl 1):I39–I42
McKeith IG, Mosimann UP (2004) Dementia with Lewy bodies and Parkinson's disease. Parkinsonism Relat Disord 10(Suppl 1):S15–S18
McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124
Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K (1995) Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color–coded real–time sonography. Neurology 45:182–184
Berg D, Siefker C, Becker G (2001) Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 248:684–689
Berg D, RoggendorfW, Schroder U, Klein R, Tatschner T, Benz P, Tucha O, Preier M, Lange KW, Reiners K, Gerlach M, Becker G (2002) Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 56:999–1005
Walter U, Wittstock M, Benecke R, Dressler D (2002) Substantia nigra echogenicity is normal in non–extrapyramidal cerebral disorders but increased in Parkinson's disease. J Neural Transm 109:191–196
Walter U, Niehaus L, Probst T, Benecke R, Meyer BU, Dressler D (2003) Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 60:74–77
Felletschin B, Bauer P, Walter U, Behnke S, Spiegel J, Csoti I, Sommer U, Zeiler B, Becker G, Riess O, Berg D (2003) Screening for mutations of the ferritin light and heavy genes in Parkinson's disease patients with hyperechogenicity of the substantia nigra. Neurosci Lett 352:53–56
Naumann M, Becker G, Toyka KV, Supprian T, Reiners K (1996) Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography. Neurology 47:1284–1290
Becker T, Becker G, Seufert J, Hofmann E, Lange KW, Naumann M, Lindner A, Reichmann H, Riederer P, Beckmann H, Reiners K (1997) Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry 63:590–596
Walter U, Dressler D, Wolters A, Probst T, Grossmann A, Benecke R (2004) Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy. Neurology 63:504–509
Seidel G, Kaps M, Gerriets T, Hutzelmann A (1995) Evaluation of the ventricular system in adults by transcranial duplex sonography. J Neuroimaging 5:105–108
Folstein MF, Folstein SE, McHugh PR (1975) "Mini–mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR (2000) A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology 55:1613–1620
Berg D, Becker G, Zeiler B, Tucha O, Hofmann E, Preier M, Benz P, Jost W, Reiners K, Lange KW (1999) Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 53:1026–1031
Berg D, Siefker C, Ruprecht–Dorfler P, Becker G (2001) Relationship of substantia nigra echogenicity and motor function in elderly subjects. Neurology 56:13–17
Litvan I, MacIntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, Bartko JJ, Jankovic J, McKee A, Brandel JP, Chaudhuri KR, Lai EC, D'Olhaberriague L, Pearce RK, Agid Y (1998) Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol 55:969–978
Hughes AJ, Daniel SE, Ben–Shlomo Y, Lees AJ (2002) The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 125:861–870
Walter U, Klein C, Hilker R, Benecke R, Pramstaller PP, Dressler D (2004) Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord 19:1445–1449
Berg D, Merz B, Reiners K, Naumann M, Becker G (2005) Five–year follow–up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord 20:383–385
Hochstrasser H, Bauer P, Walter U, Behnke S, Spiegel J, Csoti I, Zeiler B, Bornemann A, Pahnke J, Becker G, Riess O, Berg D (2004) Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology 63:1912–1917
Forstl H, Burns A, Luthert P, Cairns N, Levy R (1993) The Lewy–body variant of Alzheimer's disease. Clinical and pathological findings. Br J Psychiatry 162:385–392
Revesz T, Holton JL (2003) Anatomopathological spectrum of tauopathies. Mov Disord 18(Suppl 6):S13–S20
Gibb WR, Luthert PJ, Marsden CD (1989) Corticobasal degeneration. Brain 112:1171–1192
Hayashi S, Wakabayashi K, Ishikawa A, Nagai H, Saito M, Maruyama M, Takahashi T, Ozawa T, Tsuji S, Takahashi H (2000) An autopsy case of autosomalrecessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene. Mov Disord 15:884–888
Neumann M, Adler S, Schluter O, Kremmer E, Benecke R, Kretzschmar HA (2000) Alpha–synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA–1, formerly Hallervorden–Spatz syndrome) with widespread cortical and brainstem–type Lewy bodies. Acta Neuropathol (Berl) 100:568–674
Castellani RJ, Siedlak SL, Perry G, Smith MA (2000) Sequestration of iron by Lewy bodies in Parkinson's disease. Acta Neuropathol (Berl) 100:111–114
Gnanalingham KK, Byrne EJ, Thornton A, Sambrook MA, Bannister P (1997) Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatry 62:243–252
Rinne JO, Laihinen A, Rinne UK, Nagren K, Bergman J, Ruotsalainen U (1993) PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease. Mov Disord 8:134–138
Tatsch K, Schwarz J, Mozley PD, Linke R, Pogarell O, Oertel WH, Fieber RS, Hahn K, Kung HF (1997) Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single–photon emission tomography. Eur J Nucl Med 24:415–421
Gilman S, Koeppe RA, Little R, An H, Junck L, Giordani B, Persad C, Heumann M, Wernette K (2004) Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease. Ann Neurol 55:774–780
Walter U, Krolikowski K, Tarnacka B, Benecke R, Czlonkowska A, Dressler D (2005) Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson's disease. Neurology 64:1726–1732
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Walter, U., Dressler, D., Wolters, A. et al. Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia. J Neurol 253, 448–454 (2006). https://doi.org/10.1007/s00415-005-0023-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-005-0023-9